From the genome to the proteome—biomarkers in colorectal cancer
✍ Scribed by Jens K. Habermann; Franz G. Bader; Christian Franke; Kaja Zimmermann; Timo Gemoll; Britta Fritzsche; Thomas Ried; Gert Auer; Hans-Peter Bruch; Uwe J. Roblick
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 370 KB
- Volume
- 393
- Category
- Article
- ISSN
- 1435-2451
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Eighteen of 78 patients (23%) with metastatic colorectal cancer developed clinically significant metastases to the central nervous system (CNS). The patients developing CNS metastases had a decreased likelihood of associated liver metastases compared to the patients without CNS metastas
## Abstract There have been no studies on specific tea polyphenol biomarkers and risk of colorectal cancer in humans. We prospectively examined the associations between validated biomarkers of specific tea polyphenols and risk of developing colorectal cancer among a cohort of 18,244 men in Shanghai
Answer to: ''The commonest primary sites